The virus’ stability, characteristics, and modes of transmission through fomites and air droplets make gastrointestinal (GI) endoscopy a high-risk procedure with potential of COVID-19 virus transmission. Such findings are concerning stakeholders in the chromoendoscopy agents market. They are increasing efforts to maintain stable supply chains for products, since healthcare professionals are faced with critical patients in emergency cases.
There is a high risk of COVID-19 transmission through infected fomites such as stethoscope, endoscope, and thermometer. Since both patient and healthcare professionals are at a risk of contracting the novel infection, healthcare systems and companies in the chromoendoscopy agents market are gaining awareness about simple precautionary measures. These include the use of double surgical masks to prevent infection in endoscopy. As such, there is a need for more studies with robust design to ascertain the exact risk of coronavirus transmission during the GI endoscopy.
The chromoendoscopy agents market is projected to expand at a modest CAGR of 3.4% during the forecast period. Dye-based chromoendoscopy is considered the gold standard for accurate detection and characterization of lesions throughout the gastrointestinal tract (GIT). However, the most challenging feature regarding dye-based chromoendoscopy as compared to current virtual chromoendoscopy technique is the longer procedural time. Thus, novel trials are being conducted by researchers, scientists, and biologists. For instance, orally ingested tablets of methylene blue combined with the bowel preparation for screening colposcopy have showed promising results in increasing adenoma detection.
Targeted biopsies of any mucosal abnormalities using dye-based chromoendoscopy, along with a combination of virtual chromoendoscopy with high magnification imaging is increasing medical outcomes.
Chromoendoscopy is playing a major role in modern endoscopic imaging. This technique aids the endoscopist in highlighting and characterizing lesions in the GIT. Spraying catheters allow the most controlled and precise application of the dye as a fine mist onto the GIT surface. In colonoscopy, good bowel preparation is critical. This is being achieved using spasmolytic agents such as scopolamine or glucagon, which can be used to avoid bowel peristalsis and an uneven distribution of the dye in some cases.
Companies in the chromoendoscopy agents market are competing to demonstrate good diagnostic yield in the evaluation of dysplastic lesions in Barrett’s oesophagus (BO) and oesophageal adenocarcinoma by enabling targeted biopsies of suspicious areas. Companies in the chromoendoscopy agents market are increasing focus on methylene blue staining to assess areas of BO.
Chromoendoscopy is emerging as an alternative to fluorescence spectroscopy, fluorescence endoscopy, and optical coherence tomography. This is evident since companies in the chromoendoscopy agents market are increasing the availability of equipment needed in chromoendoscopy. The interest in chromoendoscopy is being heightened with the development of technologies such as endoscopic mucosal resection and phytodynamic therapy that require precise visual tissue characterization.
Chromoendoscopy is being used in conjunction with developments in endoscopic imaging such as confocal endomicroscopy, confocal endocytoscopy, and magnification endoscopy. Companies in the chromoendoscopy agents market are benefitting from these findings, as these techniques are simple, quick, inexpensive, and safe. On the other hand, acetic acid is being used in the detection of dysplasia within a region of the BO. Companies in the chromoendoscopy agents market are increasing their R&D in optical chromoendoscopy, which is a method that involves digital image processing performed by an endoscope and can produce nearly comparable results to spray chromoendoscopy.
Colonoscopy is being associated with decline in colorectal cancer risk and mortality with the help of detection and resection of precursor lesions. However, its role for preventing the colorectal cancer still has limitations. Companies in the chromoendoscopy agents market are capitalizing on this opportunity to deploy image enhancement techniques to improve the diagnostic yield of colonoscopy and optimize the management of colorectal lesions.
Colonoscopy is one of the most effective diagnostic and therapeutic tools for the prevention of colorectal cancer by detection and removal of precursor lesions. Companies in the chromoendoscopy agents market are increasing the availability of dye-based chromoendoscopy to help oncologists advance in diagnosis of colorectal cancer.
The virtual chromoendoscopy (VCE) is gaining popularity in the chromoendoscopy agents market to augment the spatial variance of light absorption and scattering properties of tissue in diagnostic and therapeutic applications. It has been found that VCE is emerging as an alternative to conventional chromoendoscopy where the stain agents are necessary. Such findings are influencing the growth of the chromoendoscopy agents market. VCE is capable of detecting spatial variations in light adsorption and scattering of target tissue, which helps in distinguishing abnormal and healthy tissue.
Introduction and adoption of virtual or electronic chromoendoscopy have made dye-based chromoendoscopy less relevant in the day-to-day clinical practice. Healthcare companies are increasing efforts to adapt to such changes in the market landscape. Virtual chromoendoscopy is found to be technically less cumbersome, easy in implementation, and saves time. VCE has become a recurring trend in the market, since the method involves image processing to enhance the vascular pattern of the mucosa. Nevertheless, chromoendoscopy still plays a major role in several conditions.
For the detection of colorectal lesions, two main substances usually indigo carmine, a contrast agent, and methylene blue, an absorptive agent, are used. Manufacturers are increasing their production capabilities in absorptive agents and contract agents to improve clinical numbers, owing to colorectal cancer. As such, crystal violet is used along with the magnification of characterization of lesions in which sub-mucosal invasion (SMI) is suspected.
Before the drop-wise instillation of crystal violet, a mucolytic agent should always be applied onto the lesion to avoid false images of invasive pattern in areas where the dye is not absorbed. Indigo carmine, a contrast agent is gaining relevancy in colon chromoendoscopy and targeted chromoendoscopy. Absorbents, such as methylene blue are being used for the pan-colonic chromoendoscopy.
Analysts’ Viewpoint
Several guidelines and recommendations for prevention of the COVID-19 transmission during endoscopy procedures are being followed by healthcare professionals. The chromoendoscopy agents market is expected to reach US$ 181.2 Mn by 2031. However, the interpretation of findings is not always straightforward, and the impact of chromoendoscopy on clinical outcomes with context to standard endoscopic and histologic methods lacks evidence. Hence, companies should increase awareness about the combination of dye-based and virtual chromoendoscopy with high magnification imaging and increase large controlled trials in the same to improve patient outcomes. The VCE uses narrow band imaging to provide enhanced version of the vascular pattern of the mucosa.
The global chromoendoscopy agents market was worth US$ 100 Mn and is projected to reach a value of US$ 200 Mn by the end of 2031
Chromoendoscopy agents market is anticipated to grow at a CAGR of 4% during the forecast period
North America accounted for a major share of the global chromoendoscopy agents market
Chromoendoscopy agents market is driven by increase in incidence of gastrointestinal diseases is a major factor expected to drive the global market during the forecast period
Key players in the global chromoendoscopy agents market include Cosmo Pharmaceuticals NV., Merck KGaA, Thermo Fisher Scientific, Provepharm Life Solutions, Enzo Life Sciences, Inc., American Regent, Inc., Micro-Tech Endoscopy, Cerba Research, Sisco Research Laboratories Pvt. Ltd., and LobaChemie Pvt. Ltd.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Chromoendoscopy Agents Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Chromoendoscopy Agents Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
5.2. Top 3 players operating in the market space
5.3. Regulatory Scenario
5.4. Pricing Analysis
5.5. Patients Journey Landscape
5.6. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Chromoendoscopy Agents Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Absorptive Agents
6.3.2. Contrast Agents
6.3.3. Reactive Agents
6.4. Market Attractiveness Analysis, by Product Type
7. Global Chromoendoscopy Agents Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Colorectal
7.3.2. Esophageal
7.3.3. Gastric
7.4. Market Attractiveness Analysis, by Application
8. Global Chromoendoscopy Agents Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgery Centers
8.3.3. Specialty Clinics
8.3.4. Diagnostic Centers
8.3.5. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Chromoendoscopy Agents Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region
10. North America Chromoendoscopy Agents Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Absorptive Agents
10.2.2. Contrast Agents
10.2.3. Reactive Agents
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Colorectal
10.3.2. Esophageal
10.3.3. Gastric
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Ambulatory Surgery Centers
10.4.3. Specialty Clinics
10.4.4. Diagnostic Centers
10.4.5. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Chromoendoscopy Agents Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Absorptive Agents
11.2.2. Contrast Agents
11.2.3. Reactive Agents
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Colorectal
11.3.2. Esophageal
11.3.3. Gastric
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Ambulatory Surgery Centers
11.4.3. Specialty Clinics
11.4.4. Diagnostic Centers
11.4.5. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Switzerland
11.5.8. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Chromoendoscopy Agents Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Absorptive Agents
12.2.2. Contrast Agents
12.2.3. Reactive Agents
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Colorectal
12.3.2. Esophageal
12.3.3. Gastric
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Ambulatory Surgery Centers
12.4.3. Specialty Clinics
12.4.4. Diagnostic Centers
12.4.5. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Chromoendoscopy Agents Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Absorptive Agents
13.2.2. Contrast Agents
13.2.3. Reactive Agents
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Colorectal
13.3.2. Esophageal
13.3.3. Gastric
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Ambulatory Surgery Centers
13.4.3. Specialty Clinics
13.4.4. Diagnostic Centers
13.4.5. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Chromoendoscopy Agents Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Absorptive Agents
14.2.2. Contrast Agents
14.2.3. Reactive Agents
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Colorectal
14.3.2. Esophageal
14.3.3. Gastric
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Ambulatory Surgery Centers
14.4.3. Specialty Clinics
14.4.4. Diagnostic Centers
14.4.5. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Company Profiles
15.1.1. Cosmo Pharmaceuticals NV
15.1.1.1. Company Overview
15.1.1.2. Company Financials
15.1.1.3. Growth Strategies
15.1.1.4. SWOT Analysis
15.1.2. Provepharm Life Solutions
15.1.2.1. Company Overview
15.1.2.2. Company Financials
15.1.2.3. Growth Strategies
15.1.2.4. SWOT Analysis
15.1.3. Enzo Life Sciences
15.1.3.1. Company Overview
15.1.3.2. Company Financials
15.1.3.3. Growth Strategies
15.1.3.4. SWOT Analysis
15.1.4. Sisco Research Laboratories Pvt. Ltd.
15.1.4.1. Company Overview
15.1.4.2. Company Financials
15.1.4.3. Growth Strategies
15.1.4.4. SWOT Analysis
15.1.5. Thermo Fisher Scientific
15.1.5.1. Company Overview
15.1.5.2. Company Financials
15.1.5.3. Growth Strategies
15.1.5.4. SWOT Analysis
15.1.6. LobaChemie Pvt. Ltd.
15.1.6.1. Company Overview
15.1.6.2. Company Financials
15.1.6.3. Growth Strategies
15.1.6.4. SWOT Analysis
15.1.7. Merck KGaA
15.1.7.1. Company Overview
15.1.7.2. Company Financials
15.1.7.3. Growth Strategies
15.1.7.4. SWOT Analysis
15.1.8. Cerba Research
15.1.8.1. Company Overview
15.1.8.2. Company Financials
15.1.8.3. Growth Strategies
15.1.8.4. SWOT Analysis
15.1.9. American Regent, Inc.
15.1.9.1. Company Overview
15.1.9.2. Company Financials
15.1.9.3. Growth Strategies
15.1.9.4. SWOT Analysis
15.1.10. Micro-Tech Endoscopy
15.1.10.1. Company Overview
15.1.10.2. Company Financials
15.1.10.3. Growth Strategies
15.1.10.4. SWOT Analysis
List of Tables
Table 01: Staining agents for chromoendoscopy
Table 02: Cost associated with Chromoendoscopy Diagnostic Procedure
Table 03: Chromoendoscopy Product Specifications
Table 04: Spray catheters for chromoendoscopy
Table 05: Global Chromoendoscopy Agents Market Revenue (US$ Mn) Forecast, by Product Type, 2017–2031
Table 06: Global Chromoendoscopy Agents Market Revenue (US$ Mn) Forecast, by Application, 2017–2031
Table 07: Global Chromoendoscopy Agents Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031
Table 08: Global Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 09: North America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 10: North America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 11: North America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 12: North America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Europe Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Europe Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 15: Europe Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 16: Europe Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Asia Pacific Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Asia Pacific Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 19: Asia Pacific Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 20: Asia Pacific Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Latin America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Latin America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 23: Latin America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 24: Latin America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 25: Middle East & Africa Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 26: Middle East & Africa Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 27: Middle East & Africa Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 28: Middle East & Africa Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figure
Figure 01: Global Chromoendoscopy Agents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 02: Global Chromoendoscopy Agents Market Value Share, by Region, 2020
Figure 03: Global Chromoendoscopy Agents Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 04: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Absorptive Agents , 2017–2031
Figure 05: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Cardiology, 2017–2031
Figure 06: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Neurology, 2017–2031
Figure 07: Global Chromoendoscopy Agents Market Attractive Analysis, by Product Type, (2021–2031)
Figure 08: Global Chromoendoscopy Agents Market Value Share Analysis, by Application, 2020 and 2031
Figure 09: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Colorectal, 2017–2031
Figure 10: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Esophageal, 2017–2031
Figure 11: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Gastric, 2017–2031
Figure 12: Global Chromoendoscopy Agents Market Attractive Analysis, by Application, (2021–2031)
Figure 13: Global Chromoendoscopy Agents Market Value Share Analysis, by End-user, 2020 and 2031
Figure 14: Global Chromoendoscopy Agents Market Attractiveness Analysis, by End-user, 2021–2031
Figure 15: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Hospitals, 2017–2031
Figure 16: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Ambulatory Surgery Centers, 2017–2031
Figure 17: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Specialty Clinics, 2017–2031
Figure 18: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Diagnostic Centers, 2017–2031
Figure 19: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Others, 2017–2031
Figure 20: Global Chromoendoscopy Agents Market Attractive Analysis, by End-user, (2021–2031)
Figure 21: Global Chromoendoscopy Agents Market Value Share Analysis, by Region, 2020 and 2031
Figure 22: Global Chromoendoscopy Agents Market Attractiveness Analysis, by Region, 2021–2031
Figure 23: North America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, 2017–2031
Figure 24: North America Chromoendoscopy Agents Market Value Share Analysis, by Country, 2020 and 2031
Figure 25: North America Chromoendoscopy Agents Market Attractiveness Analysis, by Country, 2021–2031
Figure 26: North America Chromoendoscopy Agents Market Value Share Analysis, by Application, 2020 and 2031
Figure 27: North America Chromoendoscopy Agents Market Attractiveness Analysis, by Application, 2021–2031
Figure 28: North America Chromoendoscopy Agents Market Value Share Analysis, by Application, 2020 and 2031
Figure 29: North America Chromoendoscopy Agents Market Attractiveness Analysis, by Application, 2021–2031
Figure 30: North America Chromoendoscopy Agents Market Value Share Analysis, by End-user, 2020 and 2031
Figure 31: North America Chromoendoscopy Agents Market Attractiveness Analysis, by End-user, 2021–2031
Figure 32: Europe Chromoendoscopy Agents Market Value (US$ Mn) Forecast, 2017–2031
Figure 33: Europe Chromoendoscopy Agents Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 34: Europe Chromoendoscopy Agents Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 35: Europe Chromoendoscopy Agents Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 36: Europe Chromoendoscopy Agents Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 37: Europe Chromoendoscopy Agents Market Value Share Analysis, by Application, 2020 and 2031
Figure 38: Europe Chromoendoscopy Agents Market Attractiveness Analysis, by Application, 2021–2031
Figure 39: Europe Chromoendoscopy Agents Market Value Share Analysis, by End-user, 2020 and 2031
Figure 40: Europe Chromoendoscopy Agents Market Attractiveness Analysis, by End-user, 2021–2031
Figure 41: Asia Pacific Chromoendoscopy Agents Market Value (US$ Mn) Forecast, 2017–2031
Figure 42: Asia Pacific Chromoendoscopy Agents Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 43: Asia Pacific Chromoendoscopy Agents Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 44: Asia Pacific Chromoendoscopy Agents Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 45: Asia Pacific Chromoendoscopy Agents Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 46: Asia Pacific Chromoendoscopy Agents Market Value Share Analysis, by Application, 2020 and 2031
Figure 47: Asia Pacific Chromoendoscopy Agents Market Attractiveness Analysis, by Application, 2021–2031
Figure 48: Asia Pacific Chromoendoscopy Agents Market Value Share Analysis, by End-user, 2020 and 2031
Figure 49: Asia Pacific Chromoendoscopy Agents Market Attractiveness Analysis, by End-user, 2021–2031
Figure 50: Latin America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, 2017–2031
Figure 51: Latin America Chromoendoscopy Agents Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 52: Latin America Chromoendoscopy Agents Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 53: Latin America Chromoendoscopy Agents Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 54: Latin America Chromoendoscopy Agents Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 55: Latin America Chromoendoscopy Agents Market Value Share Analysis, by Application, 2020 and 2031
Figure 56: Latin America Chromoendoscopy Agents Market Attractiveness Analysis, by Application, 2021–2031
Figure 57: Latin America Chromoendoscopy Agents Market Value Share Analysis, by End-user, 2020 and 2031
Figure 58: Latin America Chromoendoscopy Agents Market Attractiveness Analysis, by End-user, 2021–2031
Figure 59: Middle East & Africa Chromoendoscopy Agents Market Value (US$ Mn) Forecast, 2017–2031
Figure 60: Middle East & Africa Chromoendoscopy Agents Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 61: Middle East & Africa Chromoendoscopy Agents Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 62: Middle East & Africa Chromoendoscopy Agents Market Value Share Analysis, by Application, 2020 and 2031
Figure 63: Middle East & Africa Chromoendoscopy Agents Market Attractiveness Analysis, by Application, 2021–2031
Figure 64: Middle East & Africa Chromoendoscopy Agents Market Value Share Analysis, by Application, 2020 and 2031
Figure 65: Middle East & Africa Chromoendoscopy Agents Market Attractiveness Analysis, by Application, 2021–2031
Figure 66: Middle East & Africa Chromoendoscopy Agents Market Value Share Analysis, by End-user, 2020 and 2031
Figure 67: Middle East & Africa Chromoendoscopy Agents Market Attractiveness Analysis, by End-user, 2021–2031
Figure 68: Position Analysis, 2020, by Tier and Size of the Company
Figure 69: Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020
Figure 70: Breakdown of Net Sales (%), by Business Segment, 2020
Figure 71: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020
Figure 72: Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019
Figure 73: Breakdown of Net Sales (%), by Geography, 2019
Figure 74: Breakdown of Net Sales (%), by Business Segment, 2019
Figure 75: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019
Figure 76: Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020
Figure 77: Breakdown of Net Sales (%), by Geography, 2020
Figure 78: Breakdown of Net Sales (%), by Business Segment, 2020
Figure 79: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020
Figure 80: Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020
Figure 81: Breakdown of Net Sales (%), by Geography, 2020
Figure 82: Breakdown of Net Sales (%), by Business Segment, 2020
Figure 83: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Chromoendoscopy Agents Market
